Ipca Laboratories Limited (IPCALAB.NS) NSE
1,526.10
+31.3(+2.09%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,526.10
+31.3(+2.09%)
Currency In INR
| Market Cap | 352.86B |
| Enterprise Value | 364.82B |
| P/E Ratio | 42.55 |
| PEG Ratio | 1.72 |
| Price/Sales Ratio | 4.07 |
| Price/Book Ratio | 5.21 |
| Enterprise/Revenue | 4.19 |
| Enterprise/EBITDA | 21.39 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.1 |
| Operating Margin | 0.26 |
| Return On Assets | 0.07 |
| Return On Equity | 0.12 |
| Revenue | 89.41B |
| Revenue/Share | 374.69 |
| Gross Profit | 58.6B |
| EBITDA | 16.67B |
| Net Income | 7.38B |
| Diluted EPS | 29.08 |
| Total Cash | 12.83B |
| Total Cash/Share | 50.57 |
| Total Debt | 12.79B |
| Total Debt/Equity | 0.17 |
| Current Ratio | 2.46 |
| Book Value Per Share | 349.45 |
| 52-Week Change | 3.75 |
| 52-Week High | 1,624 |
| 52-Week Low | 1,251.6 |
| Moving Average 50 Days | 1,502.79 |
| Moving Average 200 Days | 1,425.31 |
| Average Volume | 213,603 |
| Shares Outstanding | 253.7M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 0.26 |
| Payout Ratio | 0.06 |
| Last Split Factor | 2:1 |
| Last Split Date | January 10, 2022 |